Crossmark

The necessity to use selective NADPH oxidase inhibitors

Crossref DOI link: https://doi.org/10.1007/s00540-018-2552-2

Published Online: 2018-09-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Satomi, Shiho

Kawahito, Shinji

Kinoshita, Hiroyuki
License Information

Text and Data Mining valid from 2018-09-19
More Information

Article History

Received: 11 August 2018

Accepted: 8 September 2018

First Online: 19 September 2018

Conflict of interest

: Hiroyuki Kinoshita is a consult of IMI Co. Ltd, Koshigaya, Saitama, Japan.